The genetic variation near insulin receptor substrate 1 (IRS1) is associated with low body fat but also impaired metabolic profile, including decreased subcutaneous-to-visceral fat ratio, increased insulin resistance, dyslipidemia, risk of diabetes and coronary artery disease, and decreased adiponectin level [49]. Here, IRS1 is linked to metabolic syndrome.